ATE345137T1 - Verwendung von 2h-(1,3)-oxazino(3,2-a)indol- derivaten zur behandlung von neuropathischem schmerz - Google Patents
Verwendung von 2h-(1,3)-oxazino(3,2-a)indol- derivaten zur behandlung von neuropathischem schmerzInfo
- Publication number
- ATE345137T1 ATE345137T1 AT04740899T AT04740899T ATE345137T1 AT E345137 T1 ATE345137 T1 AT E345137T1 AT 04740899 T AT04740899 T AT 04740899T AT 04740899 T AT04740899 T AT 04740899T AT E345137 T1 ATE345137 T1 AT E345137T1
- Authority
- AT
- Austria
- Prior art keywords
- oxazino
- treatment
- neuropathic pain
- indole derivatives
- indole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001467A ITMI20031467A1 (it) | 2003-07-18 | 2003-07-18 | Farmaco attivo nel dolore neuropatico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE345137T1 true ATE345137T1 (de) | 2006-12-15 |
Family
ID=34131193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04740899T ATE345137T1 (de) | 2003-07-18 | 2004-07-08 | Verwendung von 2h-(1,3)-oxazino(3,2-a)indol- derivaten zur behandlung von neuropathischem schmerz |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20060211691A1 (de) |
| EP (1) | EP1646391B1 (de) |
| JP (1) | JP2006528142A (de) |
| KR (1) | KR20060033784A (de) |
| CN (1) | CN100409850C (de) |
| AR (1) | AR045993A1 (de) |
| AT (1) | ATE345137T1 (de) |
| AU (1) | AU2004262876B2 (de) |
| CA (1) | CA2526852C (de) |
| DE (1) | DE602004003252T2 (de) |
| DK (1) | DK1646391T3 (de) |
| EA (1) | EA008927B1 (de) |
| ES (1) | ES2276317T3 (de) |
| GE (1) | GEP20084307B (de) |
| HK (1) | HK1087027A1 (de) |
| IL (1) | IL172156A0 (de) |
| IT (1) | ITMI20031467A1 (de) |
| PL (1) | PL1646391T3 (de) |
| PT (1) | PT1646391E (de) |
| UA (1) | UA81050C2 (de) |
| WO (1) | WO2005014001A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101103157B1 (ko) * | 2006-12-26 | 2012-01-04 | 다이호야쿠힌고교 가부시키가이샤 | 당뇨병성 뉴로퍼시 치료제 |
| DE102007058504A1 (de) | 2007-12-05 | 2009-07-09 | Acino Ag | Transdermales therapeutisches System mit einem Gehalt an einem Modulator für nikotinische Acetylcholinrezeptoren (nAChR) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5189041A (en) * | 1990-11-16 | 1993-02-23 | Syntex (U.S.A.) Inc. | Tricyclic 5-ht3 receptor antagonists |
| GB9120628D0 (en) * | 1991-09-27 | 1991-11-06 | Fujisawa Pharmaceutical Co | Pyrrolobenzoxazine derivatives and process for preparation thereof |
| PT884319E (pt) * | 1992-03-12 | 2004-09-30 | Smithkline Beecham Plc | N-¬(1-n-butil-4-piperidil)metil|-3,4-di-hidro-2h-¬1,3|oxazino¬3,2-a|indole-10-carboxamida ou um seu sal farmaceuticamente aceitavel |
| IL117438A (en) * | 1995-03-16 | 2001-12-23 | Lilly Co Eli | Indazolecarboxamides, their preparation and pharmaceutical compositions containing them |
| EP1200086A4 (de) * | 1999-08-04 | 2009-05-27 | Icagen Inc | Methoden zur behandlung oder vorbeugung von schmerzen und angstzuständen |
| US20040038874A1 (en) * | 2002-08-22 | 2004-02-26 | Osemwota Omoigui | Method of treatment of persistent pain |
-
2003
- 2003-07-18 IT IT001467A patent/ITMI20031467A1/it unknown
-
2004
- 2004-07-08 WO PCT/EP2004/007633 patent/WO2005014001A1/en active IP Right Grant
- 2004-07-08 JP JP2006520721A patent/JP2006528142A/ja active Pending
- 2004-07-08 DK DK04740899T patent/DK1646391T3/da active
- 2004-07-08 EA EA200600270A patent/EA008927B1/ru not_active IP Right Cessation
- 2004-07-08 PL PL04740899T patent/PL1646391T3/pl unknown
- 2004-07-08 ES ES04740899T patent/ES2276317T3/es not_active Expired - Lifetime
- 2004-07-08 CA CA2526852A patent/CA2526852C/en not_active Expired - Fee Related
- 2004-07-08 KR KR1020067000490A patent/KR20060033784A/ko active IP Right Grant
- 2004-07-08 AU AU2004262876A patent/AU2004262876B2/en not_active Ceased
- 2004-07-08 US US10/560,836 patent/US20060211691A1/en not_active Abandoned
- 2004-07-08 DE DE602004003252T patent/DE602004003252T2/de not_active Expired - Lifetime
- 2004-07-08 PT PT04740899T patent/PT1646391E/pt unknown
- 2004-07-08 AT AT04740899T patent/ATE345137T1/de active
- 2004-07-08 CN CNB2004800172642A patent/CN100409850C/zh not_active Expired - Fee Related
- 2004-07-08 EP EP04740899A patent/EP1646391B1/de not_active Expired - Lifetime
- 2004-07-08 GE GEAP20049233A patent/GEP20084307B/en unknown
- 2004-07-15 AR ARP040102486A patent/AR045993A1/es not_active Application Discontinuation
- 2004-08-07 UA UAA200600306A patent/UA81050C2/uk unknown
-
2005
- 2005-11-24 IL IL172156A patent/IL172156A0/en not_active IP Right Cessation
-
2006
- 2006-06-28 HK HK06107281A patent/HK1087027A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004262876A1 (en) | 2005-02-17 |
| EP1646391B1 (de) | 2006-11-15 |
| CA2526852A1 (en) | 2005-02-17 |
| DE602004003252T2 (de) | 2007-05-03 |
| HK1087027A1 (en) | 2006-10-06 |
| PT1646391E (pt) | 2007-01-31 |
| CN100409850C (zh) | 2008-08-13 |
| ES2276317T3 (es) | 2007-06-16 |
| EP1646391A1 (de) | 2006-04-19 |
| AR045993A1 (es) | 2005-11-23 |
| AU2004262876B2 (en) | 2010-05-20 |
| JP2006528142A (ja) | 2006-12-14 |
| GEP20084307B (en) | 2008-02-11 |
| ITMI20031467A1 (it) | 2005-01-19 |
| CA2526852C (en) | 2011-08-30 |
| EA200600270A1 (ru) | 2006-06-30 |
| WO2005014001A9 (en) | 2005-05-26 |
| KR20060033784A (ko) | 2006-04-19 |
| PL1646391T3 (pl) | 2007-04-30 |
| IL172156A0 (en) | 2006-04-10 |
| CN1809361A (zh) | 2006-07-26 |
| US20060211691A1 (en) | 2006-09-21 |
| UA81050C2 (en) | 2007-11-26 |
| WO2005014001A1 (en) | 2005-02-17 |
| DK1646391T3 (da) | 2007-03-19 |
| DE602004003252D1 (de) | 2006-12-28 |
| EA008927B1 (ru) | 2007-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| ATE458731T1 (de) | Pyrimidin-derivate zur behandlung von anormalem zellwachstum | |
| DE60325770D1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
| DE602004022061D1 (de) | Verwendung von modifizierten cyclosporinen zur behandlung von hcv-erkrankungen | |
| DK1562932T3 (da) | 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter | |
| DE602004021585D1 (de) | 5,7-DIAMINOPYRAZOLOi4,3-D PYRIMIDINE ZUR VERWENDUNG IN DER BEHANDLUNG VON BLUTHOCHDRUCK | |
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| DE60325209D1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
| ATE331512T1 (de) | Verwendung azetidinone-substituierter verbindungen zur behandlung der sitosterolhämie | |
| DE50009504D1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
| ATE316077T1 (de) | Pyrimidin-essigsäure derivate geeignet zur behandlung von crth2-bedingten krankheiten | |
| NL1025071A1 (nl) | Verbindingen voor de behandeling van abnormale celgroei. | |
| DE60108754D1 (de) | Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum | |
| DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
| DE60208221D1 (de) | Heterozyklische verbindungen zur behandlung von harnwegserkrankungen | |
| DE602004003952D1 (de) | Substituierte tetrahydrobenzothienopyrimidinamine verbindungen geeignet zur behandlung von hyper-proliferative disorders | |
| DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| NO20045554L (no) | Fremgangsmate for behandling av diabetes | |
| DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
| DE602004022153D1 (de) | Verbindungen zur behandlung von obesitas | |
| DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
| DE60238765D1 (de) | Carbamatverbindungen zur behandlung von schmerz | |
| DE60325855D1 (de) | Rifampicin zur Behandlung der Angiogenese |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1646391 Country of ref document: EP |